Deutsch English Français

Contact

EP1285272

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1285272

EP1285272 - COMPOSITIONS AND METHODS FOR SCREENING THERAPEUTIC AGENTS [Right-click to bookmark this link]
Status	The application has been refused Status updated on 14.02.2014 Database last updated on 30.10.2024
Most recent event Tooltip	14.02.2014	Refusal of application	published on 19.03.2014 [2014/12]
Applicant(s)	For all designated states biOasis Technologies Inc. 3489 Canterbury Place Surrey, BC V3S 0G8 / CA
	[2010/25]
Former [2003/09]	For all designated states University of British Columbia Industry Liaison Office, 111-2386 East Mall Vancouver, British Columbia V6T 1Z3 / CA
Inventor(s)	01 / CHENG, Nick 2979 Panorama Drive Unit 66 Coquitlam, British Columbia V3E 2W8 / CA
	02 / GAGNIER, Liane 8527 Aquitania Place Vancouver, British Columbia V5S 4V7 / CA
	03 / JEFFERIES, Wilfred, A. 12596 - 23rd Avenue South Surrey, British Columbia V4A 2C4 / CA
	[2003/09]
Representative(s)	Chapman, Paul Gilmour, et al Marks & Clerk LLP Atholl Exchange 6 Canning Street Edinburgh EH3 8EG / GB
	[2013/42]
Former [2003/09]	Chapman, Paul Gilmour, et al Cruikshank & Fairweather, 19 Royal Exchange Square Glasgow G1 3AE / GB
Application number, filing date	01903549.2	08.02.2001
	[2003/09]
	WO2001CA00133
Priority number, date	US20000181091P	08.02.2000 Original published format: US 181091 P
	[2003/09]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO0159459
	Date:	16.08.2001
	Language:	EN
	[2001/33]
	Type:	A2 Application without search report
	No.:	EP1285272
	Date:	26.02.2003
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 16.08.2001 takes the place of the publication of the European patent application.
	[2003/09]
Search report(s)	International search report - published on:	EP	28.11.2002
Classification	IPC:	G01N33/68, A01K67/027, C07K14/79, C07K16/18	[2003/09]
	CPC:	G01N33/6896 (EP,US); G01N2333/4709 (EP,US); G01N2500/00 (EP,US); G01N2800/2821 (EP,US)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/09]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	ZUSAMMENSETZUNGEN UND VERFAHREN ZUM SCREENEN VON THERAPEUTISCHEN AGENZIEN	[2003/09]
	English:	COMPOSITIONS AND METHODS FOR SCREENING THERAPEUTIC AGENTS	[2003/09]
	French:	COMPOSITIONS ET PROCEDES DE SELECTION D'AGENTS THERAPEUTIQUES	[2003/09]
Entry into regional phase	28.08.2002	National basic fee paid
	28.08.2002	Designation fee(s) paid
	28.08.2002	Examination fee paid
Examination procedure	07.09.2001	Request for preliminary examination filed International Preliminary Examining Authority: EP
	27.08.2002	Amendment by applicant (claims and/or description)
	28.08.2002	Examination requested [2003/09]
	10.09.2008	Despatch of a communication from the examining division (Time limit: M02)
	14.11.2008	Reply to a communication from the examining division
	23.02.2010	Despatch of a communication from the examining division (Time limit: M02)
	05.05.2010	Reply to a communication from the examining division
	10.12.2010	Despatch of a communication from the examining division (Time limit: M04)
	07.04.2011	Reply to a communication from the examining division
	10.02.2012	Despatch of a communication from the examining division (Time limit: M06)
	02.08.2012	Reply to a communication from the examining division
	06.09.2012	Despatch of a communication from the examining division (Time limit: M04)
	09.01.2013	Reply to a communication from the examining division
	22.10.2013	Cancellation of oral proceeding that was planned for 21.11.2013
	04.11.2013	Despatch of communication that the application is refused, reason: substantive examination [2014/12]
	14.11.2013	Application refused, date of legal effect [2014/12]
	21.11.2013	Date of oral proceedings (cancelled)
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 10.09.2008
Fees paid	Renewal fee
	25.02.2003	Renewal fee patent year 03
	23.02.2004	Renewal fee patent year 04
	22.02.2005	Renewal fee patent year 05
	14.08.2006	Renewal fee patent year 06
	14.02.2007	Renewal fee patent year 07
	13.02.2008	Renewal fee patent year 08
	13.02.2009	Renewal fee patent year 09
	16.02.2010	Renewal fee patent year 10
	25.02.2011	Renewal fee patent year 11
	27.02.2012	Renewal fee patent year 12
	28.02.2013	Renewal fee patent year 13
	Penalty fee
	Additional fee for renewal fee
	28.02.2006	06 M06 Fee paid on 14.08.2006
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[DAX]WO9401463 (UNIV BRITISH COLUMBIA [CA], et al) [DA] 1-3 * abstract * [X] 8-12;
		[DA]WO9708560 (UNIV BRITISH COLUMBIA [CA], et al) [DA] 8-12 * the whole document *;
		[A] - NAKAMASU K ET AL, "MEMBRANE-BOUND TRANSFERRIN-LIKE PROTEIN (MTF): STRUCTURE, EVOLUTIONAND SELECTIVE EXPRESSION DURING CHONDROGENIC DIFFERENTATION OF MOUSE EMBRYONIC CELLS", BIOCHIMICA ET BIOPHYSICA ACTA, AMSTERDAM, NL, (19991028), vol. 1447, ISSN 0006-3002, pages 258 - 264, XP002934313 [A] 1-3,8-12 * abstract *
		[ ] - "Membrane-bound transferrin-like protein p97", EMBL, XP002189421 [ ] * abstract *
		[A] - ZHONG MING QIAN ET AL, "EXPRESSION OF IRON TRANSPORT PROTEINS AND EXCESSIVE IRON ACCUMULATION IN THE BRAIN IN NEURODEGENERATIVE DISORDERS", BRAIN RESEARCH REVIEWS, ELSEVIER, XX, (1998), vol. 27, no. 3, ISSN 0165-0173, pages 257 - 267, XP001031265 [A] 1-3,8-12 * abstract * * page 259, column R, paragraph 2 - page 260, column R, paragraph 1 * DOI: http://dx.doi.org/10.1016/S0165-0173(98)00012-5
	Examination	- K. HSIAO ET AL, "Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice", SCIENCE, (19961004), vol. 274, no. 5284, doi:10.1126/science.274.5284.99, ISSN 0036-8075, pages 99 - 103, XP055017958 DOI: http://dx.doi.org/10.1126/science.274.5284.99
		- KAWAMOTO T ET AL, "EXPRESSION OF MEMBRANE-BOUND TRANSFERRIN-LIKE PROTEIN P97 ON THE CELL SURFACE OF CHONDROCYTES", EUROPEAN JOURNAL OF BIOCHEMISTRY, BLACKWELL PUBLISHING, BERLIN, DE, (19980101), vol. 256, no. 3, doi:10.1046/J.1432-1327.1998.2560503.X, ISSN 0014-2956, pages 503 - 509, XP002934314 DOI: http://dx.doi.org/10.1046/j.1432-1327.1998.2560503.x
		- Young ET AL, "Delivery of iron to human cells by bovine transferrin. Implications for the growth of human cells in vitro.", Biochemical Journal, (19900101), vol. 265, no. 2, ISSN 0264-6021, pages 587 - 591, XP055058250 DOI: http://dx.doi.org/10.1042/bj2650587
		- JEFFERIES W A ET AL, "REACTIVE MICROGLIA SPECIFICALLY ASSOCIATED WITH AMYLOID PLAQUES IN ALZHEIMER'S DISEASE BRAIN TISSUE EXPRESS MELANOTRANSFERRIN", BRAIN RESEARCH, ELSEVIER, AMSTERDAM, NL, (19960101), vol. 712, no. 1, doi:10.1016/0006-8993(95)01407-1, ISSN 0006-8993, pages 122 - 126, XP000613250 DOI: http://dx.doi.org/10.1016/0006-8993(95)01407-1
		- KENNARD M L ET AL, "SERUM LEVELS OF THE IRON BINDING PROTEIN P97 ARE ELEVATED IN ALZHEIMER'S DISEASE", NATURE MEDICINE, NATURE PUBLISHING GROUP, NEW YORK, NY, US, (19861101), vol. 2, no. 11, doi:10.1038/NM1196-1230, ISSN 1078-8956, pages 1230 - 1235, XP000613536 DOI: http://dx.doi.org/10.1038/nm1196-1230
	by applicant	US4736866
		US5141742
		US5262177
		- HSIAO ET AL., "Alzheimer's Disease (AD) prone mouse.", SCIENCE, (1996), vol. 274, pages 99 - 102
		- KENNARD ET AL., NATURE MEDICINE, (1996), vol. 2, pages 1230 - 1235
		- WILCHEK; BAYER, "The Avidin-Biotin Complex in Bioanalytical Applications", ANAL BIOCHEM., (1988), vol. 171, doi:doi:10.1016/0003-2697(88)90120-0, pages 1 - 32, XP024829207 DOI: http://dx.doi.org/10.1016/0003-2697(88)90120-0
		- HAMMER ET AL., NATURE, (1985), vol. 315, pages 680 - 683
		- PALMITER ET AL., SCIENCE, (1983), vol. 222, pages 809 - 814
		- BRINSTER ET AL., PROC NATL. ACAD. SCI USA, (1985), vol. 82, pages 4438 - 4442
		- PALMITER; BRINSTER, CELL, (1985), vol. 41, pages 343 - 345
		- CAPECCHI, NATURE, (1993), vol. 362, pages 255 - 258
		- JAKOBOVITS ET AL., NATURE, (1993), vol. 362, pages 255 - 258
		- MORGAN ET AL., ANN. REPORTS MED. CHEM., (1989), vol. 24, pages 243 - 252
		- SIMON ET AL., PROC. NATL. ACAD, SCI USA, (1972), vol. 89, page 9367
		WO1996CA00587

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p